{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:27:28Z","timestamp":1787923648209,"version":"build-2784847793"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.msard.2026.107408","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T15:29:11Z","timestamp":1784993351000},"page":"107408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of smoking on clinical outcomes in NMOSD and MOGAD: A meta-analysis"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1115-4610","authenticated-orcid":false,"given":"Bassel","family":"Alrabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Matar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Bandak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durrah","family":"Khlaif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Alrabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Own S.","family":"Almohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8515-941X","authenticated-orcid":false,"given":"Loay","family":"Abu-Irsheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeel","family":"Al Kayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107408_bib0001","article-title":"Unravelling the complexity of Myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"16","author":"Abbas","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.msard.2026.107408_bib0002","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/biom12040591","article-title":"Aquaporin-4 in Neuromyelitis Optica Spectrum Disorders: a target of autoimmunity in the Central nervous system","volume":"12","author":"Abe","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.msard.2026.107408_bib0003","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/ijms22010100","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management","volume":"22","author":"Ambrosius","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107408_bib0004","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14712598.2021.1884223","article-title":"Targeting the complement system in neuromyelitis optica spectrum disorder","volume":"21","author":"Asavapanumas","year":"2021","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.msard.2026.107408_bib0005","article-title":"Pain in NMOSD and MOGAD: a Systematic Literature Review of pathophysiology, symptoms, and current treatment strategies","volume":"11","author":"Asseyer","year":"2020","journal-title":"Front. Neurol. Volume"},{"key":"10.1016\/j.msard.2026.107408_bib0006","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet. Neurol."},{"key":"10.1016\/j.msard.2026.107408_bib0021","first-page":"259","article-title":"The effect of smoking on MRI lesion resolution in NMOSD-AQP4 and MOGAD","volume":"9","author":"Berhanu","year":"2025","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107408_bib0007","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/WCO.0000000000001044","article-title":"Progression in multiple sclerosis - a long-term problem","volume":"35","author":"Bittner","year":"2022","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.msard.2026.107408_bib0008","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fneur.2018.00888","article-title":"Diagnosis and treatment of NMO spectrum disorder and MOG-encephalomyelitis","volume":"9","author":"Borisow","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107408_bib0009","doi-asserted-by":"crossref","first-page":"12970","DOI":"10.3390\/ijms131012970","article-title":"Molecular pathogenesis of neuromyelitis optica","volume":"13","author":"Bukhari","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107408_bib0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncl.2023.06.009","article-title":"Updates in NMOSD and MOGAD diagnosis and treatment: a tale of two Central nervous system autoimmune inflammatory disorders","volume":"42","author":"Cacciaguerra","year":"2024","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.msard.2026.107408_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2021.108365","article-title":"Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer","volume":"787","author":"Caliri","year":"2021","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"10.1016\/j.msard.2026.107408_bib0012","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s40120-022-00432-x","article-title":"Characterization of disease severity and stability in NMOSD: a global clinical record review with patient interviews","volume":"12","author":"Capobianco","year":"2023","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.msard.2026.107408_bib0013","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/01.CIR.88.5.2149","article-title":"Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults","volume":"88","author":"Celermajer","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.msard.2026.107408_bib0014","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-319-93791-5_2","article-title":"Data analysis using R programming","volume":"1082","author":"Chan","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.msard.2026.107408_bib0026","first-page":"259","article-title":"Smoking status and vascular risk factors as predictors of disability in AQP4-NMOSD and MOGAD","volume":"9","author":"Chan","year":"2018","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107408_bib0015","doi-asserted-by":"crossref","first-page":"8638","DOI":"10.3390\/ijms22168638","article-title":"Treatment of Neuromyelitis Optica spectrum disorders","volume":"22","author":"Chan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107408_bib0016","doi-asserted-by":"crossref","first-page":"22279","DOI":"10.3390\/ijms151222279","article-title":"Smoking and rheumatoid arthritis","volume":"15","author":"Chang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107408_bib0017","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.3390\/biomedicines13102344","article-title":"MOGAD: a shifting landscape\u2014From pathogenesis to personalised management, global perspectives and latin american insights","volume":"13","author":"Ciampi","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.msard.2026.107408_bib0018","first-page":"1","article-title":"Induction of immune tolerance in NMOSD and MOGAD. Ther","volume":"18","author":"Correale","year":"2025","journal-title":"Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2026.107408_bib0019","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/0961203306069344","article-title":"Cigarette smoking and autoimmune disease: what can we learn from epidemiology?","volume":"15","author":"Costenbader","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.msard.2026.107408_bib0022","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.26858","article-title":"Time to disability milestones and annualized relapse rates in NMOSD and MOGAD","volume":"95","author":"Duchow","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107408_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119543","article-title":"Signaling pathways driving multiple sclerosis: from mechanisms to natural\u2011product interventions","volume":"200","author":"El-Dessouki","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.msard.2026.107408_bib0024","first-page":"93","article-title":"Association of cigarette smoking with neuromyelitis opticaimmunoglobulin G sero-positivity in neuromyelitis optica spectrum disorder","volume":"18","author":"Eskandarieh","year":"2019","journal-title":"Curr. J. Neurol."},{"key":"10.1016\/j.msard.2026.107408_bib0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13760-018-0900-5","article-title":"Environmental risk factors in neuromyelitis optica spectrum disorder: a case\u2013control study","volume":"118","author":"Eskandarieh","year":"2018","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.msard.2026.107408_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/610813","article-title":"Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF","volume":"2015","author":"Fischer","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.msard.2026.107408_bib0028","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200268","article-title":"Serum proteomics distinguish subtypes of NMO spectrum disorder and MOG antibody-associated disease and highlight effects of B-cell depletion","volume":"11","author":"Gawde","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"10.1016\/j.msard.2026.107408_bib0029","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41433-020-01334-8","article-title":"Neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disorder-optic neuritis: a comprehensive review of diagnosis and treatment","volume":"35","author":"Gospe","year":"2021","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.msard.2026.107408_bib0030","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/WNL.0000000000001001","article-title":"Protective environmental factors for neuromyelitis optica","volume":"83","author":"Graves","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107408_bib0031","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/ane.12916","article-title":"Smoking and worsening disability in multiple sclerosis: a meta-analysis","volume":"138","author":"Heydarpour","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2026.107408_bib0032","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jneuroim.2012.09.006","article-title":"Inflammation and oxidative stress induced by cigarette smoke in Lewis rat brains","volume":"254","author":"Khanna","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107408_bib0033","article-title":"Neuromyelitis Optica spectrum disorder initially presenting with meningitis-like symptoms: a case report","volume":"18","author":"Kubo","year":"2026","journal-title":"Cureus"},{"key":"10.1016\/j.msard.2026.107408_bib0034","first-page":"43","article-title":"The potential pathogenicity of myelin oligodendrocyte glycoprotein antibodies in the optic pathway","author":"Lerch","year":"2023","journal-title":"J. Neuro-Ophthalmol."},{"key":"10.1016\/j.msard.2026.107408_bib0035","first-page":"1316","article-title":"Tobacco smoke exposure and oxidative stress: the role of circulating lipopolysaccharides in heated and conventional products","volume":"14","author":"Loffredo","year":"2025","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.msard.2026.107408_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102773","article-title":"The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis","volume":"49","author":"Messina","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107408_bib0037","doi-asserted-by":"crossref","first-page":"8538","DOI":"10.3390\/ijms26178538","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: pathophysiology, clinical patterns, and therapeutic challenges of intractable and severe forms","volume":"26","author":"Misu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107408_bib0038","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.msard.2026.107408_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-025-07429-0","article-title":"The impact of oxidative stress on symptoms associated with multiple sclerosis","volume":"15","author":"Pi\u00f1ar-Morales","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107408_bib0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.18632\/oncotarget.13613","article-title":"Impacts of cigarette smoking on immune responsiveness: up and down or upside down?","volume":"8","author":"Qiu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.msard.2026.107408_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1793855","article-title":"Dissecting NMOSD pathogenesis through animal models: a mechanism-oriented systems perspective","volume":"17","author":"Qiu","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107408_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42466-026-00490-8","article-title":"Preventive strategies in neuroimmunology","volume":"8","author":"Riemann-Lorenz","year":"2026","journal-title":"Neurol. Res. Pract."},{"key":"10.1016\/j.msard.2026.107408_bib0043","first-page":"321","article-title":"CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease","volume":"68","author":"Rosenthal","year":"2020","journal-title":"J. Investig. Med. Off. Publ. Am. Fed. Clin. Res."},{"key":"10.1016\/j.msard.2026.107408_bib0020","first-page":"259","article-title":"A national case\u2013control study investigating demographic and environmental factors associated with NMOSD","volume":"9","author":"Rotstein","year":"2023","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107408_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2026.107223","article-title":"Patient reported outcomes in NMOSD reflect a high disease burden and do not correlate with the EDSS","volume":"111","author":"Saeedzadeh","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107408_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578781","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): practical recommendations for diagnosis and management","volume":"410","author":"Sechi","year":"2026","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107408_bib0046","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/1352458514551780","article-title":"Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis","volume":"21","author":"Simon","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107408_bib0047","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.msard.2026.107408_bib0048","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.3390\/app13085029","article-title":"Neuromyelitis optica spectrum disorders: clinical perspectives, molecular mechanisms, and treatments","volume":"13","author":"Thangaleela","year":"2023","journal-title":"Appl. Sci."},{"key":"10.1016\/j.msard.2026.107408_bib0049","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum","volume":"20","author":"Uzawa","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2026.107408_bib0050","first-page":"1","article-title":"Environmental triggers and autoimmunity","volume":"2014","author":"Vojdani","year":"2014","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.msard.2026.107408_bib0051","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1756285611425694","article-title":"Smoking: effects on multiple sclerosis susceptibility and disease progression","volume":"5","author":"Wingerchuk","year":"2012","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2026.107408_bib0052","article-title":"A preliminary study of association of cigarette smoking with risk of neuromyelitis optica spectrum disorder","volume":"100","author":"Yang","year":"2021","journal-title":"Med. (United States)"},{"key":"10.1016\/j.msard.2026.107408_bib0053","doi-asserted-by":"crossref","DOI":"10.1177\/17562864251328276","article-title":"Advances in the treatment of neuromyelitis optic spectrum disorder","volume":"18","author":"Yang","year":"2025","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2026.107408_bib0054","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1177\/13524585261429292","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease and relapse risk: effects of smoking and vascular risk factors","volume":"32","author":"Yeh","year":"2026","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107408_bib0055","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fimmu.2018.01438","article-title":"Aquaporin-4 autoantibodies from Neuromyelitis Optica spectrum disorder patients induce complement-independent immunopathologies in mice","volume":"9","author":"Yick","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826004438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826004438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:48:32Z","timestamp":1787921312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826004438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"alternative-id":["S2211034826004438"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107408","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of smoking on clinical outcomes in NMOSD and MOGAD: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107408"}}